GlassScriptPhysician profile
Rami Alrabaa
NPI 1336503267
$22,201.63
in general payments reported to CMS, 2019-2025
22 companies · $6,347 in 2025
The $6,347 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8,198 · 2022: $2,945 · 2023: $1,083 · 2024: $3,629 · 2025: $6,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,924 · Education: $4,440 · Consulting Fee: $936 · Travel and Lodging: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,924.35 |
| Education | $4,440.00 |
| Consulting Fee | $935.50 |
| Travel and Lodging | $759.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $8,184.37 | 2021 | |
| Kerecis Limited | $6,250.26 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Stryker Corporation | $3,458.53 | 2022-2025 | Inspace, Iconix, Alphavent |
| Seapearl East, INC | $1,718.87 | 2022-2025 | |
| Depuy Synthes Sales INC. | $736.23 | 2022-2024 | Na, Milagro, Healix Knotless Peek |
| Skeletal Dynamics INC | $489.00 | 2024 | Geminus, Implate, Align |
| Hikma Pharmaceuticals USA | $343.50 | 2024 | Combogesic IV |
| Medartis INC. | $327.26 | 2023-2024 | Aptus |
| Linvatec Corporation | $252.53 | 2022-2024 | Biobrace 23mm, Allograft Tissue |
| Anika Therapeutics, INC. | $194.30 | 2024 | Integrity |
| Zimmer Biomet Holdings, INC. | $41.26 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Globus Medical, INC. | $30.96 | 2024 | Distal Radius II |
| Abbott Laboratories | $25.41 | 2024 | Freestyle Libre 3 |
| Orthofix Medical, INC. | $21.07 | 2025 | Physio-Stim |
| Bioventus LLC | $18.44 | 2025 | Durolane |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $17.22 | 2025 | Dexcom G6 Transmitter |
| Ferring Pharmaceuticals INC. | $17.00 | 2023 | Euflexxa |
| Axogen | $17.00 | 2024 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Endo USA, INC. | $16.42 | 2025 | Xiaflex |
| Xeris Pharmaceuticals, INC. | $14.51 | 2024 | Gvoke Hypopen |
| Amgen INC. | $14.32 | 2025 | Evenity |
| Smith+Nephew, INC. | $13.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Alrabaa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.